CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer. [electronic resource]
Producer: 20180305Description: 707-716 p. digitalISSN:- 1557-3265
- 4-1BB Ligand -- immunology
- Antibodies, Monoclonal -- pharmacology
- Antigen Presentation
- Antigens, Neoplasm -- immunology
- Antineoplastic Agents, Immunological -- pharmacology
- Carcinoma, Squamous Cell -- immunology
- Cell Line, Tumor
- Cetuximab -- pharmacology
- Cytokines -- metabolism
- Dendritic Cells -- drug effects
- Gene Expression Regulation, Neoplastic -- genetics
- Genotype
- Head and Neck Neoplasms -- immunology
- Humans
- Killer Cells, Natural -- drug effects
- Lymphocytes -- drug effects
- Lymphocytes, Tumor-Infiltrating -- drug effects
- Polymorphism, Genetic
- Receptor Cross-Talk -- drug effects
- Receptors, IgG -- genetics
- Tumor Necrosis Factor Receptor Superfamily, Member 9 -- agonists
- Up-Regulation -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.